Editas Medicine to Present at Upcoming June Investor Conferences

CAMBRIDGE, Mass., May 24, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will present company overviews at three upcoming investor conferences in June:

• Goldman Sachs 37th Annual Global Healthcare Conference on Wednesday, June 8, 2016 at 4:00 p.m. PT (7:00 p.m. ET) in Rancho Palos Verdes, Calif.
   
• Jefferies 2016 Healthcare Conference on Thursday, June 9, 2016 at 4:30 p.m. ET in New York City
   
• JMP Securities 2016 Life Sciences Conferenceon Tuesday, June 21, 2016 at 11:00 a.m. ET in New York City

A live webcast of each presentation will be available on the Investors & Media section of the Editas website at www.editasmedicine.com. An archived replay will be available for approximately 30 days following the presentation.
                                         
About Editas Medicine
Editas Medicine is a leading genome editing company dedicated to treating patients with genetically-defined diseases by correcting their disease-causing genes. The Company was founded by world leaders in genome editing, and its mission is to translate the promise of genome editing science into a broad class of transformative genomic medicines to benefit the greatest number of patients.

Media Contact
Dan Budwick
Pure Communications, Inc.
(973) 271-6085
dan@purecommunicationsinc.com

Investor Contact
Jesse Baumgartner
Stern Investor Relations, Inc.
(212) 362-1200
jesse@sternir.com

Editas Medicine